Your browser doesn't support javascript.
loading
Recurrence of pulmonary tuberculosis in India: Findings from the 2019-2021 nationwide community-based TB prevalence survey.
Giridharan, Prathiksha; Selvaraju, Sriram; Rao, Raghuram; Rade, Kiran; Thiruvengadam, Kannan; Asthana, Smita; Balachandar, Rakesh; Dipak Bangar, Sampada; Bansal, Avi Kumar; Bhat, Jyothi; Chakraborty, Debjit; Chopra, Vishal; Das, Dasarathi; Dutta, Shanta; Rekha Devi, Kangjam; Kumar, Sunil; Laxmaiah, Avula; Madhukar, Major; Mahapatra, Amarendra; Mohanty, Suman Sundar; Rangaraju, Chethana; Turuk, Jyotirmayee; Zaman, Kamran; Krishnan, Rajendran; Shanmugam, Sivakumar; Kumar, Nishant; Panduranga Joshi, Rajendra; Narasimhaiah, Somashekar; Chandrasekaran, Padmapriyadarsini; Gangakhedkar, Raman R; Bhargava, Balram.
Afiliação
  • Giridharan P; ICMR- National Institute for Research in Tuberculosis, Chetpet, Chennai, India.
  • Selvaraju S; ICMR- National Institute for Research in Tuberculosis, Chetpet, Chennai, India.
  • Rao R; Central TB Division, Ministry of Health and Family Welfare, New Delhi, India.
  • Rade K; National Professional Officer, WHO Country Office, New Delhi, India.
  • Thiruvengadam K; ICMR- National Institute for Research in Tuberculosis, Chetpet, Chennai, India.
  • Asthana S; ICMR- National Institute for Cancer Prevention and Research, Noida, Uttar Pradesh, India.
  • Balachandar R; ICMR- National Institute for Occupational Health, Ahmedabad, Gujarat, India.
  • Dipak Bangar S; ICMR- National AIDS Research Institute, Pune, Maharashtra, India.
  • Bansal AK; ICMR- National JALMA Institute of Leprosy and other Mycobacterial diseases, Agra, Uttar Pradesh, India.
  • Bhat J; ICMR- National Institute for research in Tribal Health, Jabalpur, Madhya Pradesh, India.
  • Chakraborty D; ICMR- National Institute of Cholera and Enteric Diseases, Kolkata, India.
  • Chopra V; State TB Training and Demonstration Centre (STDC), TB Hospital, Lahori, Punjab, India.
  • Das D; ICMR- Regional Medical Research Centre, Bhubaneshwar, Odisha, India.
  • Dutta S; ICMR- National Institute of Cholera and Enteric Diseases, Kolkata, India.
  • Rekha Devi K; ICMR- Regional Medical Research Centre, Dibrugarh, Assam, India.
  • Kumar S; State TB Cell, Trivandrum, Kerala, India.
  • Laxmaiah A; ICMR- National Institute for Research in Nutrition, Hyderabad, Telangana, India.
  • Madhukar M; ICMR- Rajendra Memorial Research Institute of Medical Sciences Agamkuan, Patna, India.
  • Mahapatra A; ICMR- Regional Medical Research Centre, Bhubaneshwar, Odisha, India.
  • Mohanty SS; ICMR- ICMR-National Institute for Implementation Research on Non-Communicable Diseases, Jodhpur, India.
  • Rangaraju C; National Tuberculosis Institute, Bengaluru, Karnataka, India.
  • Turuk J; ICMR- Regional Medical Research Centre, Bhubaneshwar, Odisha, India.
  • Zaman K; ICMR- Regional Medical Research Centre, Gorakhpur.
  • Krishnan R; ICMR- National Institute for Research in Tuberculosis, Chetpet, Chennai, India.
  • Shanmugam S; ICMR- National Institute for Research in Tuberculosis, Chetpet, Chennai, India.
  • Kumar N; Central TB Division, Ministry of Health and Family Welfare, New Delhi, India.
  • Panduranga Joshi R; Central TB Division, Ministry of Health and Family Welfare, New Delhi, India.
  • Narasimhaiah S; National Tuberculosis Institute, Bengaluru, Karnataka, India.
  • Chandrasekaran P; ICMR- National Institute for Research in Tuberculosis, Chetpet, Chennai, India.
  • Gangakhedkar RR; Indian Council of Medical Research, New Delhi, India.
  • Bhargava B; Indian Council of Medical Research, New Delhi, India.
PLoS One ; 18(12): e0294254, 2023.
Article em En | MEDLINE | ID: mdl-38127931
ABSTRACT
Recurrent Tuberculosis patients contribute to a significant proportion of TB burden in India. A nationwide survey was conducted during 2019-2021 across India among adults to estimate the prevalence of TB. A total of 322480 individuals were screened and 1402 were having TB. Of this, 381 (27.1%) had recurrent TB. The crude prevalence (95% CI) of recurrent TB was 118 (107-131) per 100,000 population. The median duration between episodes of TB was 24 months. The proportion of drug resistant TB was 11.3% and 3.6% in the recurrent group and new TB patients respectively. Higher prevalence of recurrent TB was observed in elderly, males, malnourished, known diabetics, smokers, and alcohol users. (p<0.001). To prevent TB recurrence, all treated tuberculosis patients must be followed at least for 24 months, with screening for Chest X-ray, liquid culture every 6 months, smoking cessation, alcohol cessation, nutritional interventions and good diabetic management.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Tuberculose / Tuberculose Pulmonar / Mycobacterium tuberculosis Limite: Adult / Aged / Humans / Male País/Região como assunto: Asia Idioma: En Revista: PLoS One Assunto da revista: CIENCIA / MEDICINA Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Índia

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Tuberculose / Tuberculose Pulmonar / Mycobacterium tuberculosis Limite: Adult / Aged / Humans / Male País/Região como assunto: Asia Idioma: En Revista: PLoS One Assunto da revista: CIENCIA / MEDICINA Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Índia